![Sandeep Kulkarni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sandeep Kulkarni
Gründer bei
ZURA BIO LIMITED
Vermögen: - $ am 31.08.2026
Profil
Dr. Sandeep C.
Kulkarni, MD, is a Chief Executive Officer & Director at Zura Bio Ltd., a Chief Executive Officer & Director at Tourmaline Sub, Inc. and a Chairman at Amanat Acquisition Corp.
He is on the Board of Directors at Zura Bio Ltd. and Tourmaline Sub, Inc. Dr. Kulkarni was previously employed as a Chief Executive Officer & Director by Tourmaline Bio, Inc., a Managing Director by KVP Capital Advisors LP, a Chief Operating Officer by Immunovant, Inc., a Vice President-Special Projects by Roivant Sciences, Inc., a Senior Analyst by Consonance Capital Management LP, an Investment Analyst by QVT Financial LP, a Consultant by The Boston Consulting Group, Inc., and a Principal by Amanat Sponsor Holdings LLC.
He received his undergraduate degree from Harvard College and a doctorate degree from The University of California, San Francisco.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
Aktive Positionen von Sandeep Kulkarni
| Unternehmen | Position | Beginn |
|---|---|---|
| ZURA BIO LIMITED | Gründer | 01.03.2022 |
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Gründer | 01.09.2021 |
Ehemalige bekannte Positionen von Sandeep Kulkarni
| Unternehmen | Position | Ende |
|---|---|---|
KVP Capital Advisors LP
 KVP Capital Advisors LP Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 01.06.2022 |
| IMMUNOVANT, INC. | Geschäftsführer | 01.06.2020 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Corporate Officer/Principal | 01.06.2020 |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial is a global multi-strategy hedge fund manager that invests in biotech and healthcare, energy and shipping, financials and structured finance, opportunistic and litigation, and technology. | Analyst-Equity | 01.08.2017 |
Ausbildung von Sandeep Kulkarni
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
QVT Financial LP
QVT Financial LP Investment ManagersFinance QVT Financial is a global multi-strategy hedge fund manager that invests in biotech and healthcare, energy and shipping, financials and structured finance, opportunistic and litigation, and technology. | Finance |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Consonance Capital Management LP
 Consonance Capital Management LP Investment ManagersFinance Consonance Capital aims to deliver exceptional, uncorrelated risk-adjusted returns through investment opportunities in the publicly traded stocks of healthcare companies. The firm seeks to meet this strategy by investing in publicly traded micro-cap, small-cap and mid-cap healthcare equities. They believe the public healthcare market lends itself to an active long/short strategy. Consonance Capital is focused on creating long and short portfolios driven by the opportunity for absolute return and alpha creation. The firm seeks to identify and analyze companies trading below their intrinsic value, which may include deep value as well as growth companies. | Finance |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KVP Capital Advisors LP
KVP Capital Advisors LP Investment ManagersFinance Provides investment advice | Finance |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
Tourmaline Bio, Inc.
Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Commercial Services |
